Nouscom will join & present at the SITC 2019
Nouscom will join & present at the SITC 2019 from November 6-10.
Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium
Nouscom will present at the 2nd European Oncology and Immono-Oncology Drug Discovery Symposium on October 22, 2019 in Basel.
Nouscom is presenting at the TMB & Neoantigen Congress
Nouscom will present at the TMB & Neoantigen Congress from October 10-11, 2019 in London.
Dr. Marina Udier, COO of Nouscom, will give a talk about our company at the BaselArea.swiss Life Science Event on June 20, 2019 in Basel
The BaselArea.swiss Life Science event will have Dr. Marina Udier, COO of Nouscom, talking about the story of the company and sharing insights and learnings along the way.
Nouscom will present at the NeoAg Summit 2018
The 3rd NeoAg Summit is the leading end-to-end industry- focused meeting dedicated to advancing neoantigen-based cancer vaccines and cell therapies. Download the full program of NeoAg Summit 2018.
Nouscom will present at the World Vaccine Congress Europe 2018
Find out the full program here: https://www.terrapinn.com/conference/world-vaccine-congress-europe/agenda.stm
Nouscom will present at Biocapital Europe
Find out the full program here: http://www.biocapitaleurope.com
NousCom presents at Agenda Sachs Forum
Full program: http://www.sachsforum.com/uploads/5/1/9/6/51964431/17thbef-finalagenda.pdf
NousCom presents at 3rd CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE
Mainz, Germany Abstract Title: Great Apes Adenovirus neoantigens vaccine synergizes with immunomodulators in mouse models of cancer.
NousCom presents at 3rd Annual Immuno-Oncology BD&L and Investment Forum
EMBL Heidelberg, Germany Full program: https://am.asco.org
